Scientist/Senior Scientist, Oncology

Senior Research Associate/Principal Research Associate, Molecular & Cell Biology

Computational Biologist, Human Epidemiology & Genetics

Associate Director, Program Management, Drug Discovery & Development

Data Scientist, Image Analysis

Director/Senior Director, Clinical Operations, Drug Development Operations

Senior HR Business Systems Analyst

Scientist, In Vivo Oncology

Associate Director/Director, Clinical Data Management

Intern, Proteomics (BS or MS)

Intern, Brain Magnetic Resonance Spectroscopy (MS or PhD)

Intern, Computational Oncology (BS or MS)

Intern, Machine Learning & Protein Engineering (MS or PhD)

Intern, Protein Expression and Purification (BS or MS)

Senior/Principal Research Associate, Flow Cytometry Technology 

Intern, Organelle Dynamics in Cell Stress Responses (MS or PhD)

Scientist, Proteomics/Post Translational Modifications

Group Leader/Associate Director, Automation

Associate Director, Biostatistics

Scientist/Senior Scientist, Mammalian Aging

Quality Assurance Manager

Senior/Principal Research Associate, Mammalian Aging

Director, Organization Development 

Data Scientist/ Senior Data Scientist, Metabolomics

Data Scientist, Genomics

1910 Genetics

20n Bio

3DBio Therapeutics

3T Biosciences

4D Molecular Therapeutics

64x Bio

8Biomed

A-Alpha Bio

A2 Biotherapeutics

AavantiBio

AB Studio

Abalone Bio

Abata Therapeutics

Abeona Therapeutics

Abintus Bio

Abiosciences

Absci

Accelevir Diagnostics

Accent Therapeutics

ACELYRIN

Acepodia

Achieve Life Sciences

Acrivon Therapeutics

Acutis Diagnostics

Adaptive Phage Therapeutics

Adcentrx Therapeutics

Adicet Bio

Aditum Bio

adMare BioInnovations

Admera Health

Adverum Biotechnologies

adyn

Aeglea BioTherapeutics

Aether Bio

Affini-T Therapeutics

Affinia Therapeutics

Affinivax

AgBiome

Agena Bioscience

Akero Therapeutics

Akouos

Alamar Biosciences

Alector

AlivaMab Discovery Services

Alkahest

Alladapt Immunotherapeutics

Allakos

Allarta Life Science

Allay Therapeutics

AlloVir

Alloy Therapeutics

AllStripes

Alltrna

Alpine Immune Sciences

Altis Biosystems

Alto Neuroscience

AltPep

Alumis

Alveo Technologies

ALX Oncology

Alzheon

Ambagon Therapeutics

Amberstone Biosciences

Ambys Medicines

Amylyx

AN2 Therapeutics

Andes

Angiocrine Bioscience

AnHeart Therapeutics

Annexon Biosciences

Ansa Biotechnologies

Antheia

Apollomics

Appia Bio

Applied Molecular Transport

Apriori Bio (Flagship)

Aptevo Therapeutics

Apton Biosystems

Aptose Biosciences

Aquinnah Pharmaceuticals

Arbor Biotechnologies

Arcadia Science

Arcellx

Arcturus Therapeutics

Arcutis Biotherapeutics

Arima Genomics

Ark Biotech

Arkuda Therapeutics

Armata Pharmaceuticals

Aro Biotherapeutics

Arpeggio Biosciences

Arrakis Therapeutics

Arranta Bio

ArsenalBio

Artisan Bio

Artiva Biotherapeutics

Ascidian Therapeutics

Ascribe Bioscience

Asher Biotherapeutics

Asimov

Calico Life Sciences is investigating the basic biology of aging using state-of-the-art technology and advanced computation. Unlike traditional biotechnology companies, Calico focuses on biology first with its wide range of equipment and facilities and uses that information to develop interventions that enable people to live longer and healthier lives. For example, Calico works with different model organisms such as yeast, worms, mice and naked mole rats. The long-term aim of Calico is to identify new targets, not being pursued by others, for diseases commonly associated with aging. Calico’s portfolio currently includes more than 20 early- and late-stage preclinical compounds in cancer, neurological diseases and tissue homeostasis and repair.

<p>Calico Life Sciences is investigating the basic biology of aging using state-of-the-art technology and advanced computation. Unlike traditional biotechnology companies, Calico focuses on biology first with its wide range of equipment and facilities and uses that information to develop interventions that enable people to live longer and healthier lives. For example, Calico works with different model organisms such as yeast, worms, mice and naked mole rats. The long-term aim of Calico is to identify new targets, not being pursued by others, for diseases commonly associated with aging. Calico’s portfolio currently includes more than 20 early- and late-stage preclinical compounds in cancer, neurological diseases and tissue homeostasis and repair.</p>


Calico Life Sciences

Find a biotech startup job.